Articles

Depletion of T regulatory cells through selection of CD127-positive cells results in a population enriched in memory T cells: implications for anti-tumor cell therapy

UPMC Univ Paris 06 and CNRS UMR7211, Immunology-Immunopathology-Immunotherapy (I3), Paris, France
INSERM, U959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France;AP-HP, Hôpital Pitié Salpêtrière, Service de Biothérapie, Paris, France
Yale Cancer Center, Department of Hematology, Yale University, New Haven, CT, USA;Department of Medical Oncology, Dana-Farber Institute, Boston and Broad Institute of MIT and Harvard, Cambridge, MA, USA
Université Paris Est Créteil, Faculté de Médicine Créteil, France;AP-HP, Groupe Hospitalier Henri-Mondor and Inserm, CIC-BT, Créteil, France
UPMC Univ Paris 06 and CNRS UMR7211, Immunology-Immunopathology-Immunotherapy (I3), Paris, France
UPMC Univ Paris 06 and CNRS UMR7211, Immunology-Immunopathology-Immunotherapy (I3), Paris, France;AP-HP, Hôpital Pitié Salpêtrière, Service de Biothérapie, Paris, France
Université Paris Est Créteil, Faculté de Médicine Créteil, France;INSERM, U 955, Institut Mondor de Recherche Biomédicale (IMRB), Créteil, France
Université Paris Est Créteil, Faculté de Médicine Créteil, France;INSERM, U 955, Institut Mondor de Recherche Biomédicale (IMRB), Créteil, France
Vol. 97 No. 11 (2012): November, 2012 https://doi.org/10.3324/haematol.2011.056374